U.S. FDA gives early approval to Sarepta's DMD gene therapy

admin December 12, 2019 0

The U.S. Food and Drug Administration on Thursday granted an early approval to Sarepta Therapeutics Inc's gene therapy for Duchenne muscular dystrophy (DMD).

from Reuters: Company News https://ift.tt/2qLbFdp
via IFTTT

Tags IFTTT Reuters: Company News

Share

25 Best CBD oils for seizures in 2022

May 17, 2022

The 6 Best CBD Oil UK Products of 2022

July 07, 2022

{getWidget} $results={3} $label={recent} $type={list1}

{getWidget} $results={3} $label={comments} $type={list1}

{getWidget} $results={3} $label={recent} $type={list}

Main Tags

no-style

Responsive Advertisement

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's.

Design by - Blogger Templates and FBT

Home
About
Contact
RTL Version

U.S. FDA gives early approval to Sarepta's DMD gene therapy

Post a Comment

Post a Comment

Contact Form